Tennant Phil (CIK 2030874) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-25). Recent activity: Buy PGEN (5,208 shares), Sell PGEN (2,585 shares), Buy PGEN (79,166 shares), Sell PGEN (79,166 shares), Sell PGEN (30,272 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-25 | PRECIGEN, INC. (PGEN) | Chief Commercial Officer | Buy | 5,208 | $0 |
| 2026-08-25 | PRECIGEN, INC. (PGEN) | Chief Commercial Officer | Sell | 2,585 | $18,612 |
| 2026-08-25 | PRECIGEN, INC. (PGEN) | Chief Commercial Officer | Buy | 79,166 | $127,457 |
| 2026-08-25 | PRECIGEN, INC. (PGEN) | Chief Commercial Officer | Sell | 79,166 | $593,745 |
| 2026-06-01 | PRECIGEN, INC. (PGEN) | Chief Commercial Officer | Sell | 30,272 | $131,986 |
| 2026-05-27 | PRECIGEN, INC. (PGEN) | Chief Commercial Officer | Buy | 62,500 | $0 |
| 2026-03-20 | PRECIGEN, INC. (PGEN) | Chief Commercial Officer | Buy | 42,110 | $0 |
| 2025-09-30 | PRECIGEN, INC. (PGEN) | Chief Commercial Officer | Buy | 6,000 | $21,480 |
| 2025-05-16 | PRECIGEN, INC. (PGEN) | Chief Commercial Officer | Buy | 66,441 | $0 |
| 2025-05-16 | PRECIGEN, INC. (PGEN) | Chief Commercial Officer | Sell | 22,969 | $33,305 |
来源：SEC Form 4 申报文件 · 截至 2026-08-25